NASDAQ:ATAI
ATA Inc. Stock News
$2.13
+0.0800 (+3.90%)
At Close: May 02, 2024
Stephen Bardin to Join atai Life Sciences as CFO Designate
10:59am, Friday, 17'th Jun 2022 GlobeNewswire Inc.
NEW YORK and BERLIN, June 17, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V., (Nasdaq: ATAI) (“atai” or the “Company”), a clinical stage biopharmaceutical company aiming to transform the t
atai Life Sciences nimmt an kommenden Gesundheitskonferenzen im Juni teil
09:40am, Friday, 17'th Jun 2022 GlobeNewswire Inc.
NEW YORK (USA) und BERLIN, June 17, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) ("atai"), ein im klinischen Stadium tätiges Biopharmaunternehmen, das die Behandlung von psychisc
atai Life Sciences to Participate in Upcoming June Healthcare Conferences
09:59am, Thursday, 16'th Jun 2022 GlobeNewswire Inc.
NEW YORK and BERLIN, June 16, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental hea
Atai Life Sciences N.V.: A First Take
12:37pm, Thursday, 02'nd Jun 2022
Shares of mental health biopharma Atai Life Sciences N.V. have fallen some two-thirds from their June 2021 IPO pricing as the biotech market continues to crater. The company's approach of identifying
Atai Life Sciences And The Future Of Psychedelics For Mental Health
07:04am, Friday, 27'th May 2022
ATAI has a large portfolio of drugs, mainly psychedelics, that can be used to treat mental health conditions when other options have failed. There is ample room for new drug developments in this space
Best Penny Stocks To Buy? 3 With Unusual Options Activity Today
01:31pm, Wednesday, 18'th May 2022
Penny stocks to watch with unusual options volume today. The post Best Penny Stocks To Buy?
atai Life Sciences' (ATAI) CEO Florian Brand on Q1 2022 Results - Earnings Call Transcript
02:02pm, Monday, 16'th May 2022
atai Life Sciences N.V. (NASDAQ:ATAI ) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Greg Weaver – Chief Financial Officer Florian Brand – Chief Executive Officer S
atai Life Sciences legt Finanzergebnisse für das erste Quartal 2022 und Unternehmens-Update vor
10:55am, Monday, 16'th May 2022 GlobeNewswire Inc.
– Starke Umsetzung der drei strategischen Säulen von atai: schnell wirkende pharmakologische Intervention, kontinuierliche digitale Unterstützung und biomarkergesteuerte Präzisionspsychiatrie
atai Life Sciences Reports First Quarter 2022 Financial Results and Business Update
10:55am, Monday, 16'th May 2022 GlobeNewswire Inc.
– Strong execution across atai’s three strategic pillars: rapid acting pharmacological intervention, ongoing digital support and biomarker-driven precision mental health
KORREKTUR - atai Life Sciences gibt Finanzergebnisse für das erste Quartal 2022 und Unternehmens-Update bekannt
07:15pm, Friday, 06'th May 2022 GlobeNewswire Inc.
NEW YORK, May 06, 2022 (GLOBE NEWSWIRE) -- In einer gestern von atai Life Sciences N.V. (Nasdaq: ATAI) veröffentlichten Mitteilung mit der Überschrift „atai Life Sciences legt Finanzergebnisse f
CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Business Update
07:19pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- In a release issued yesterday under the headline "atai Life Sciences to Announce First-Quarter 2022 Financial Results" by atai Life Sciences N.V. (Nasdaq:
CORRECTION - atai Life Sciences to Announce First Quarter 2022 Financial Results and Business Update
03:19pm, Thursday, 05'th May 2022
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- In a release issued yesterday under the headline "atai Life Sciences to Announce First-Quarter 2022 Financial Results" by atai Life Sciences N.V. (Nasdaq: AT
atai Life Sciences legt Finanzergebnisse für das erste Quartal 2022 vor
06:10pm, Wednesday, 04'th May 2022 GlobeNewswire Inc.
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) („atai“), ein biopharmazeutisches Unternehmen im klinischen Stadium, das anstrebt, die Behandlung von psychische
atai Life Sciences to Announce First-Quarter 2022 Financial Results
08:00am, Wednesday, 04'th May 2022 GlobeNewswire Inc.
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorder
atai Life Sciences to Announce First-Quarter 2022 Financial Results
04:00am, Wednesday, 04'th May 2022
NEW YORK, May 04, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,
